Global Viral Vaccines Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Viral Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Viral Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Viral Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Viral Vaccines Segment by Type

2.2.1 Attenuated Vaccine

2.2.2 Inactivated Vaccine

2.3 Viral Vaccines Sales by Type

2.3.1 Global Viral Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Viral Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Viral Vaccines Sale Price by Type (2017-2022)

2.4 Viral Vaccines Segment by Application

2.4.1 Hospital

2.4.2 Pharmaceutical Factory

2.4.3 Research Institute

2.4.4 Others

2.5 Viral Vaccines Sales by Application

2.5.1 Global Viral Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Viral Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Viral Vaccines Sale Price by Application (2017-2022)

3 Global Viral Vaccines by Company

3.1 Global Viral Vaccines Breakdown Data by Company

3.1.1 Global Viral Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Viral Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Viral Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Viral Vaccines Revenue by Company (2020-2022)

3.2.2 Global Viral Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Viral Vaccines Sale Price by Company

3.4 Key Manufacturers Viral Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Viral Vaccines Product Location Distribution

3.4.2 Players Viral Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Viral Vaccines by Geographic Region

4.1 World Historic Viral Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Viral Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Viral Vaccines Annual Revenue by Geographic Region

4.2 World Historic Viral Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Viral Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Viral Vaccines Annual Revenue by Country/Region

4.3 Americas Viral Vaccines Sales Growth

4.4 APAC Viral Vaccines Sales Growth

4.5 Europe Viral Vaccines Sales Growth

4.6 Middle East & Africa Viral Vaccines Sales Growth

5 Americas

5.1 Americas Viral Vaccines Sales by Country

5.1.1 Americas Viral Vaccines Sales by Country (2017-2022)

5.1.2 Americas Viral Vaccines Revenue by Country (2017-2022)

5.2 Americas Viral Vaccines Sales by Type

5.3 Americas Viral Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Viral Vaccines Sales by Region

6.1.1 APAC Viral Vaccines Sales by Region (2017-2022)

6.1.2 APAC Viral Vaccines Revenue by Region (2017-2022)

6.2 APAC Viral Vaccines Sales by Type

6.3 APAC Viral Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Viral Vaccines by Country

7.1.1 Europe Viral Vaccines Sales by Country (2017-2022)

7.1.2 Europe Viral Vaccines Revenue by Country (2017-2022)

7.2 Europe Viral Vaccines Sales by Type

7.3 Europe Viral Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Viral Vaccines by Country

8.1.1 Middle East & Africa Viral Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Viral Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Viral Vaccines Sales by Type

8.3 Middle East & Africa Viral Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Viral Vaccines

10.3 Manufacturing Process Analysis of Viral Vaccines

10.4 Industry Chain Structure of Viral Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Viral Vaccines Distributors

11.3 Viral Vaccines Customer

12 World Forecast Review for Viral Vaccines by Geographic Region

12.1 Global Viral Vaccines Market Size Forecast by Region

12.1.1 Global Viral Vaccines Forecast by Region (2023-2028)

12.1.2 Global Viral Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Viral Vaccines Forecast by Type

12.7 Global Viral Vaccines Forecast by Application

13 Key Players Analysis

13.1 GSK

13.1.1 GSK Company Information

13.1.2 GSK Viral Vaccines Product Offered

13.1.3 GSK Viral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GSK Main Business Overview

13.1.5 GSK Latest Developments

13.2 Merck

13.2.1 Merck Company Information

13.2.2 Merck Viral Vaccines Product Offered

13.2.3 Merck Viral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Main Business Overview

13.2.5 Merck Latest Developments

13.3 Novartis

13.3.1 Novartis Company Information

13.3.2 Novartis Viral Vaccines Product Offered

13.3.3 Novartis Viral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Novartis Main Business Overview

13.3.5 Novartis Latest Developments

13.4 Pfizer

13.4.1 Pfizer Company Information

13.4.2 Pfizer Viral Vaccines Product Offered

13.4.3 Pfizer Viral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Pfizer Main Business Overview

13.4.5 Pfizer Latest Developments

13.5 Sanofi

13.5.1 Sanofi Company Information

13.5.2 Sanofi Viral Vaccines Product Offered

13.5.3 Sanofi Viral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Sanofi Main Business Overview

13.5.5 Sanofi Latest Developments

13.6 Bayer

13.6.1 Bayer Company Information

13.6.2 Bayer Viral Vaccines Product Offered

13.6.3 Bayer Viral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bayer Main Business Overview

13.6.5 Bayer Latest Developments

13.7 Zoetis

13.7.1 Zoetis Company Information

13.7.2 Zoetis Viral Vaccines Product Offered

13.7.3 Zoetis Viral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Zoetis Main Business Overview

13.7.5 Zoetis Latest Developments

13.8 AstraZeneca

13.8.1 AstraZeneca Company Information

13.8.2 AstraZeneca Viral Vaccines Product Offered

13.8.3 AstraZeneca Viral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 AstraZeneca Main Business Overview

13.8.5 AstraZeneca Latest Developments

13.9 Johnson

13.9.1 Johnson Company Information

13.9.2 Johnson Viral Vaccines Product Offered

13.9.3 Johnson Viral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Johnson Main Business Overview

13.9.5 Johnson Latest Developments

13.10 CSL

13.10.1 CSL Company Information

13.10.2 CSL Viral Vaccines Product Offered

13.10.3 CSL Viral Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 CSL Main Business Overview

13.10.5 CSL Latest Developments

14 Research Findings and Conclusion

Table 1. Viral Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Viral Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Attenuated Vaccine

Table 4. Major Players of Inactivated Vaccine

Table 5. Global Viral Vaccines Sales by Type (2017-2022) & (K MT)

Table 6. Global Viral Vaccines Sales Market Share by Type (2017-2022)

Table 7. Global Viral Vaccines Revenue by Type (2017-2022) & ($ million)

Table 8. Global Viral Vaccines Revenue Market Share by Type (2017-2022)

Table 9. Global Viral Vaccines Sale Price by Type (2017-2022) & (USD/MT)

Table 10. Global Viral Vaccines Sales by Application (2017-2022) & (K MT)

Table 11. Global Viral Vaccines Sales Market Share by Application (2017-2022)

Table 12. Global Viral Vaccines Revenue by Application (2017-2022)

Table 13. Global Viral Vaccines Revenue Market Share by Application (2017-2022)

Table 14. Global Viral Vaccines Sale Price by Application (2017-2022) & (USD/MT)

Table 15. Global Viral Vaccines Sales by Company (2020-2022) & (K MT)

Table 16. Global Viral Vaccines Sales Market Share by Company (2020-2022)

Table 17. Global Viral Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Viral Vaccines Revenue Market Share by Company (2020-2022)

Table 19. Global Viral Vaccines Sale Price by Company (2020-2022) & (USD/MT)

Table 20. Key Manufacturers Viral Vaccines Producing Area Distribution and Sales Area

Table 21. Players Viral Vaccines Products Offered

Table 22. Viral Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Viral Vaccines Sales by Geographic Region (2017-2022) & (K MT)

Table 26. Global Viral Vaccines Sales Market Share Geographic Region (2017-2022)

Table 27. Global Viral Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Viral Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Viral Vaccines Sales by Country/Region (2017-2022) & (K MT)

Table 30. Global Viral Vaccines Sales Market Share by Country/Region (2017-2022)

Table 31. Global Viral Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Viral Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Viral Vaccines Sales by Country (2017-2022) & (K MT)

Table 34. Americas Viral Vaccines Sales Market Share by Country (2017-2022)

Table 35. Americas Viral Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Viral Vaccines Revenue Market Share by Country (2017-2022)

Table 37. Americas Viral Vaccines Sales by Type (2017-2022) & (K MT)

Table 38. Americas Viral Vaccines Sales Market Share by Type (2017-2022)

Table 39. Americas Viral Vaccines Sales by Application (2017-2022) & (K MT)

Table 40. Americas Viral Vaccines Sales Market Share by Application (2017-2022)

Table 41. APAC Viral Vaccines Sales by Region (2017-2022) & (K MT)

Table 42. APAC Viral Vaccines Sales Market Share by Region (2017-2022)

Table 43. APAC Viral Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Viral Vaccines Revenue Market Share by Region (2017-2022)

Table 45. APAC Viral Vaccines Sales by Type (2017-2022) & (K MT)

Table 46. APAC Viral Vaccines Sales Market Share by Type (2017-2022)

Table 47. APAC Viral Vaccines Sales by Application (2017-2022) & (K MT)

Table 48. APAC Viral Vaccines Sales Market Share by Application (2017-2022)

Table 49. Europe Viral Vaccines Sales by Country (2017-2022) & (K MT)

Table 50. Europe Viral Vaccines Sales Market Share by Country (2017-2022)

Table 51. Europe Viral Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Viral Vaccines Revenue Market Share by Country (2017-2022)

Table 53. Europe Viral Vaccines Sales by Type (2017-2022) & (K MT)

Table 54. Europe Viral Vaccines Sales Market Share by Type (2017-2022)

Table 55. Europe Viral Vaccines Sales by Application (2017-2022) & (K MT)

Table 56. Europe Viral Vaccines Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Viral Vaccines Sales by Country (2017-2022) & (K MT)

Table 58. Middle East & Africa Viral Vaccines Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Viral Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Viral Vaccines Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Viral Vaccines Sales by Type (2017-2022) & (K MT)

Table 62. Middle East & Africa Viral Vaccines Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Viral Vaccines Sales by Application (2017-2022) & (K MT)

Table 64. Middle East & Africa Viral Vaccines Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Viral Vaccines

Table 66. Key Market Challenges & Risks of Viral Vaccines

Table 67. Key Industry Trends of Viral Vaccines

Table 68. Viral Vaccines Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Viral Vaccines Distributors List

Table 71. Viral Vaccines Customer List

Table 72. Global Viral Vaccines Sales Forecast by Region (2023-2028) & (K MT)

Table 73. Global Viral Vaccines Sales Market Forecast by Region

Table 74. Global Viral Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Viral Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Viral Vaccines Sales Forecast by Country (2023-2028) & (K MT)

Table 77. Americas Viral Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Viral Vaccines Sales Forecast by Region (2023-2028) & (K MT)

Table 79. APAC Viral Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Viral Vaccines Sales Forecast by Country (2023-2028) & (K MT)

Table 81. Europe Viral Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Viral Vaccines Sales Forecast by Country (2023-2028) & (K MT)

Table 83. Middle East & Africa Viral Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Viral Vaccines Sales Forecast by Type (2023-2028) & (K MT)

Table 85. Global Viral Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Viral Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Viral Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Viral Vaccines Sales Forecast by Application (2023-2028) & (K MT)

Table 89. Global Viral Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Viral Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Viral Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 92. GSK Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 93. GSK Viral Vaccines Product Offered

Table 94. GSK Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 95. GSK Main Business

Table 96. GSK Latest Developments

Table 97. Merck Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 98. Merck Viral Vaccines Product Offered

Table 99. Merck Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 100. Merck Main Business

Table 101. Merck Latest Developments

Table 102. Novartis Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 103. Novartis Viral Vaccines Product Offered

Table 104. Novartis Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 105. Novartis Main Business

Table 106. Novartis Latest Developments

Table 107. Pfizer Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 108. Pfizer Viral Vaccines Product Offered

Table 109. Pfizer Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 110. Pfizer Main Business

Table 111. Pfizer Latest Developments

Table 112. Sanofi Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 113. Sanofi Viral Vaccines Product Offered

Table 114. Sanofi Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 115. Sanofi Main Business

Table 116. Sanofi Latest Developments

Table 117. Bayer Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 118. Bayer Viral Vaccines Product Offered

Table 119. Bayer Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 120. Bayer Main Business

Table 121. Bayer Latest Developments

Table 122. Zoetis Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 123. Zoetis Viral Vaccines Product Offered

Table 124. Zoetis Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 125. Zoetis Main Business

Table 126. Zoetis Latest Developments

Table 127. AstraZeneca Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 128. AstraZeneca Viral Vaccines Product Offered

Table 129. AstraZeneca Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 130. AstraZeneca Main Business

Table 131. AstraZeneca Latest Developments

Table 132. Johnson Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 133. Johnson Viral Vaccines Product Offered

Table 134. Johnson Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 135. Johnson Main Business

Table 136. Johnson Latest Developments

Table 137. CSL Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 138. CSL Viral Vaccines Product Offered

Table 139. CSL Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 140. CSL Main Business

Table 141. CSL Latest Developments

List of Figures

Figure 1. Picture of Viral Vaccines

Figure 2. Viral Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Viral Vaccines Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Viral Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Viral Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Attenuated Vaccine

Figure 10. Product Picture of Inactivated Vaccine

Figure 11. Global Viral Vaccines Sales Market Share by Type in 2021

Figure 12. Global Viral Vaccines Revenue Market Share by Type (2017-2022)

Figure 13. Viral Vaccines Consumed in Hospital

Figure 14. Global Viral Vaccines Market: Hospital (2017-2022) & (K MT)

Figure 15. Viral Vaccines Consumed in Pharmaceutical Factory

Figure 16. Global Viral Vaccines Market: Pharmaceutical Factory (2017-2022) & (K MT)

Figure 17. Viral Vaccines Consumed in Research Institute

Figure 18. Global Viral Vaccines Market: Research Institute (2017-2022) & (K MT)

Figure 19. Viral Vaccines Consumed in Others

Figure 20. Global Viral Vaccines Market: Others (2017-2022) & (K MT)

Figure 21. Global Viral Vaccines Sales Market Share by Application (2017-2022)

Figure 22. Global Viral Vaccines Revenue Market Share by Application in 2021

Figure 23. Viral Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Viral Vaccines Revenue Market Share by Company in 2021

Figure 25. Global Viral Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Viral Vaccines Revenue Market Share by Geographic Region in 2021

Figure 27. Global Viral Vaccines Sales Market Share by Region (2017-2022)

Figure 28. Global Viral Vaccines Revenue Market Share by Country/Region in 2021

Figure 29. Americas Viral Vaccines Sales 2017-2022 (K MT)

Figure 30. Americas Viral Vaccines Revenue 2017-2022 ($ Millions)

Figure 31. APAC Viral Vaccines Sales 2017-2022 (K MT)

Figure 32. APAC Viral Vaccines Revenue 2017-2022 ($ Millions)

Figure 33. Europe Viral Vaccines Sales 2017-2022 (K MT)

Figure 34. Europe Viral Vaccines Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Viral Vaccines Sales 2017-2022 (K MT)

Figure 36. Middle East & Africa Viral Vaccines Revenue 2017-2022 ($ Millions)

Figure 37. Americas Viral Vaccines Sales Market Share by Country in 2021

Figure 38. Americas Viral Vaccines Revenue Market Share by Country in 2021

Figure 39. United States Viral Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Viral Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Viral Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Viral Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Viral Vaccines Sales Market Share by Region in 2021

Figure 44. APAC Viral Vaccines Revenue Market Share by Regions in 2021

Figure 45. China Viral Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Viral Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Viral Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Viral Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Viral Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Viral Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Viral Vaccines Sales Market Share by Country in 2021

Figure 52. Europe Viral Vaccines Revenue Market Share by Country in 2021

Figure 53. Germany Viral Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Viral Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Viral Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Viral Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Viral Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Viral Vaccines Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Viral Vaccines Revenue Market Share by Country in 2021

Figure 60. Egypt Viral Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Viral Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Viral Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Viral Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Viral Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Viral Vaccines in 2021

Figure 66. Manufacturing Process Analysis of Viral Vaccines

Figure 67. Industry Chain Structure of Viral Vaccines

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles